Abstract
Deficiency of 3-hydroxy-3-methylglutaryl-coenzyme A (CoA) lyase affects the metabolism of leucine as well as ketogenesis. This disorder is one of an increasing list of inborn errors of metabolism that presents clinically like Reye's Syndrome or nonketotic hypoglycemia. Four patients with proven 3-hydroxy-3-methylglutaryl-CoA lyase deficiency were shown to excrete a new diagnostically specific metabolite. The technique of fast atom bombardment and tandem mass spectrometry revealed that only 3-methylglutaryl-CoA is a substrate for acylcarnitine formation. Neither 3-methylglutaconyl-CoA nor 3-hydroxy-3-methylglutaryl-CoA are excreted as acylcarnitines. The excretion of 3-methylglutarylcarnitine may explain, in part, the apparent secondary carnitine deficiency in this disorder. Carnitine supplementation with moderate dietary restrictions may be a useful treatment strategy for this disorder.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bohmer T., Bremer J. Propionylcarnitine. Physiological variations in vivo. Biochim Biophys Acta. 1968 May 1;152(3):559–567. doi: 10.1016/0005-2760(68)90096-9. [DOI] [PubMed] [Google Scholar]
- Brass E. P., Hoppel C. L. Carnitine metabolism in the fasting rat. J Biol Chem. 1978 Apr 25;253(8):2688–2693. [PubMed] [Google Scholar]
- Chalmers R. A., Roe C. R., Stacey T. E., Hoppel C. L. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res. 1984 Dec;18(12):1325–1328. doi: 10.1203/00006450-198412000-00021. [DOI] [PubMed] [Google Scholar]
- Faull K., Bolton P., Halpern B., Hammond J., Danks D. M., Hähnel R., Wilkinson S. P., Wysocki S. J., Masters P. L. Letter: Patient with defect in leucine metabolism. N Engl J Med. 1976 Apr 29;294(18):1013–1013. doi: 10.1056/nejm197604292941823. [DOI] [PubMed] [Google Scholar]
- Millington D. S., Roe C. R., Maltby D. A. Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Biomed Mass Spectrom. 1984 May;11(5):236–241. doi: 10.1002/bms.1200110508. [DOI] [PubMed] [Google Scholar]
- Roe C. R., Hoppel C. L., Stacey T. E., Chalmers R. A., Tracey B. M., Millington D. S. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child. 1983 Nov;58(11):916–920. doi: 10.1136/adc.58.11.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe C. R., Millington D. S., Maltby D. A., Bohan T. P., Hoppel C. L. L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest. 1984 Jun;73(6):1785–1788. doi: 10.1172/JCI111387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe C. R., Millington D. S., Maltby D. A., Bohan T. P., Kahler S. G., Chalmers R. A. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. Pediatr Res. 1985 May;19(5):459–466. doi: 10.1203/00006450-198505000-00011. [DOI] [PubMed] [Google Scholar]
- Roe C. R., Millington D. S., Maltby D. A., Kahler S. G., Bohan T. P. L-carnitine therapy in isovaleric acidemia. J Clin Invest. 1984 Dec;74(6):2290–2295. doi: 10.1172/JCI111657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe C. R., Millington D. S., Maltby D. A., Kinnebrew P. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. J Pediatr. 1986 Jan;108(1):13–18. doi: 10.1016/s0022-3476(86)80762-4. [DOI] [PubMed] [Google Scholar]
- Stacey T. E., de Sousa C., Tracey B. M., Whitelaw A., Mistry J., Timbrell P., Chalmers R. A. Dizygotic twins with 3-hydroxy-3-methylglutaric aciduria; unusual presentation, family studies and dietary management. Eur J Pediatr. 1985 Jul;144(2):177–181. doi: 10.1007/BF00451909. [DOI] [PubMed] [Google Scholar]